Skip to main content
. 2020 Sep 13;10:311. doi: 10.1038/s41398-020-0862-2

Fig. 1. Altered brain activation in participants at clinical high risk of psychosis (CHR) and effect of cannabidiol (CBD).

Fig. 1

a Fear processing in the CHR-placebo vs control group. Clusters showing greater (red/yellow) or reduced (blue/green) activation in participants at clinical high risk receiving placebo compared with healthy controls during fear processing. b Fear processing in the CHR-CBD vs CHR-placebo group. Clusters showing greater (red/yellow) or reduced (blue/green) activation in participants at clinical high risk receiving cannabidiol (CBD) compared with those receiving placebo during fear processing. The right side of the brain is shown on the right of the images.